BioSpace News Archive

Pharm Country

Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference

Aclaris Therapeutics, Inc. today announced that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the H.C. Wainwright BioConnect Virtual Conference, which will be available beginning on Monday, January 10, 2022 at 7:00 a.m. ET.

December 27, 2021
·
1 min read
Drug Development

BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study

BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced topline results from Month 12 (Part A) of ATTRibute-CM, an ongoing global Phase 3 study investigating acoramidis for the treatment of symptomatic transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM).

December 27, 2021
·
10 min read
FDA

FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program

BrainStorm Cell Therapeutics Inc. today announced plans for a dosing extension of NurOwn® for participants who completed the Expanded Access Protocol (EAP).

December 27, 2021
·
7 min read
Business

Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China

Partnership builds on the current progress and strength of ongoing clinical trials for STRO-002 in ovarian and endometrial cancer.

December 27, 2021
·
8 min read
Business

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21 million in a Series A-1 round.

December 27, 2021
·
2 min read
Biotech Beach

TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial

TRACON Pharmaceuticals today announced the Independent Data Monitoring Committee (IDMC) for the ongoing ENVASARC pivotal trial recommended continued accrual as planned in both cohort A of single agent envafolimab and cohort B of envafolimab given with Yervoy (ipilimumab).

December 27, 2021
·
6 min read
Drug Development

PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC

PharmAbcine Inc. today announced it has dosed the first patient in its Phase II clinical trial evaluating the combination of olinvacimab, PharmAbcine’s anti-VEGFR2.

December 27, 2021
·
4 min read
Pharm Country

Sentinel Capital Partners Acquires TTG Imaging Solutions

Sentinel Capital Partners today announced its acquisition of TTG Imaging Solutions, a leading national provider of nuclear medicine and molecular imaging solutions.

December 27, 2021
·
2 min read
Drug Development

Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

Moleculin Biotech, Inc. today reported preliminary interim results from its U.S. Phase 1b/2 clinical trial as it concluded the safety review of the third cohort and opens the fourth cohort in a dose escalation trial evaluating Annamycin.

December 27, 2021
·
9 min read
Biotech Beach

Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market

Sorrento Therapeutics, Inc. has executed a second contract with a large distributor for the sale and distribution of up to 10 million COVISTIX™ tests for the Mexican market.

December 27, 2021
·
4 min read